108 related articles for article (PubMed ID: 25982535)
21. A B-cell-associated gene signature classification of diffuse large B-cell lymphoma by NanoString technology.
Michaelsen TY; Richter J; Brøndum RF; Klapper W; Johnsen HE; Albertsen M; Dybkær K; Bøgsted M
Blood Adv; 2018 Jul; 2(13):1542-1546. PubMed ID: 29967255
[TBL] [Abstract][Full Text] [Related]
22. Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphoma.
Roberts RA; Sabalos CM; LeBlanc ML; Martel RR; Frutiger YM; Unger JM; Botros IW; Rounseville MP; Seligmann BE; Miller TP; Grogan TM; Rimsza LM
Lab Invest; 2007 Oct; 87(10):979-97. PubMed ID: 17700562
[TBL] [Abstract][Full Text] [Related]
23. MicroRNAs are suitable for assessment as biomarkers from formalin-fixed paraffin-embedded tissue, and miR-24 represents an appropriate reference microRNA for diffuse large B-cell lymphoma studies.
Culpin RE; Sieniawski M; Proctor SJ; Menon G; Mainou-Fowler T
J Clin Pathol; 2013 Mar; 66(3):249-52. PubMed ID: 23172553
[TBL] [Abstract][Full Text] [Related]
24. Angiomirs expression profiling in diffuse large B-Cell lymphoma.
Borges NM; do Vale Elias M; Fook-Alves VL; Andrade TA; de Conti ML; Macedo MP; Begnami MD; Campos AH; Etto LY; Bortoluzzo AB; Alves AC; Young KH; Colleoni GW
Oncotarget; 2016 Jan; 7(4):4806-16. PubMed ID: 26683099
[TBL] [Abstract][Full Text] [Related]
25. Tissue microarray in a subset of South African patients with DLBCL.
Sissolak G; Wood L; Smith L; Chan JW; Armitage J; Jacobs P
Transfus Apher Sci; 2013 Oct; 49(2):120-32. PubMed ID: 23942329
[TBL] [Abstract][Full Text] [Related]
26. Utility of reverse transcriptase - Multiplex ligation-dependant probe amplification (RT-MLPA) in the molecular classification of Diffuse Large B cell lymphoma (DLBCL) by cell-of-origin (COO).
Dcunha N; Sakhti D; Sigamani E; Chandramohan J; Korula A; George B; Manipadam MT; Pai R
Indian J Pathol Microbiol; 2023; 66(4):714-719. PubMed ID: 38084521
[TBL] [Abstract][Full Text] [Related]
27. Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome.
Barrans SL; Crouch S; Care MA; Worrillow L; Smith A; Patmore R; Westhead DR; Tooze R; Roman E; Jack AS
Br J Haematol; 2012 Nov; 159(4):441-53. PubMed ID: 22970711
[TBL] [Abstract][Full Text] [Related]
28. Bioinformatic validation identifies candidate key genes in diffuse large-B cell lymphoma.
Huang Q; Liu F; Shen J
Per Med; 2019 Jul; 16(4):313-323. PubMed ID: 31331250
[No Abstract] [Full Text] [Related]
29. High concordance of gene expression profiling-correlated immunohistochemistry algorithms in diffuse large B-cell lymphoma, not otherwise specified.
Hwang HS; Park CS; Yoon DH; Suh C; Huh J
Am J Surg Pathol; 2014 Aug; 38(8):1046-57. PubMed ID: 24705314
[TBL] [Abstract][Full Text] [Related]
30. Molecular subtyping of diffuse large B-cell lymphoma: update on biology, diagnosis and emerging platforms for practising pathologists.
Gifford GK; Gill AJ; Stevenson WS
Pathology; 2016 Jan; 48(1):5-16. PubMed ID: 27020203
[TBL] [Abstract][Full Text] [Related]
31. Molecular classification of primary mediastinal large B-cell lymphoma using routinely available tissue specimens.
Mottok A; Wright G; Rosenwald A; Ott G; Ramsower C; Campo E; Braziel RM; Delabie J; Weisenburger DD; Song JY; Chan WC; Cook JR; Fu K; Greiner T; Smeland E; Holte H; Savage KJ; Glinsmann-Gibson BJ; Gascoyne RD; Staudt LM; Jaffe ES; Connors JM; Scott DW; Steidl C; Rimsza LM
Blood; 2018 Nov; 132(22):2401-2405. PubMed ID: 30257882
[TBL] [Abstract][Full Text] [Related]
32. Efficient identification of miRNAs for classification of tumor origin.
Søkilde R; Vincent M; Møller AK; Hansen A; Høiby PE; Blondal T; Nielsen BS; Daugaard G; Møller S; Litman T
J Mol Diagn; 2014 Jan; 16(1):106-15. PubMed ID: 24211363
[TBL] [Abstract][Full Text] [Related]
33. DNA methylation signatures define molecular subtypes of diffuse large B-cell lymphoma.
Shaknovich R; Geng H; Johnson NA; Tsikitas L; Cerchietti L; Greally JM; Gascoyne RD; Elemento O; Melnick A
Blood; 2010 Nov; 116(20):e81-9. PubMed ID: 20610814
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
Tagawa H
Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
[TBL] [Abstract][Full Text] [Related]
35. Molecular Classification of Diffuse Large B-cell Lymphoma: What Is Clinically Relevant?
Sujobert P; Salles G; Bachy E
Hematol Oncol Clin North Am; 2016 Dec; 30(6):1163-1177. PubMed ID: 27888873
[TBL] [Abstract][Full Text] [Related]
36. Bcl-2 molecular analysis in paraffin-embedded biopsies from diffuse large B-cell lymphomas.
De Brasi C; Narbaitz M; Rodriguez A; Larripa I; Slavutsky I
Medicina (B Aires); 2000; 60(3):305-10. PubMed ID: 11050805
[TBL] [Abstract][Full Text] [Related]
37. BCL2 expression is a prognostic marker for the activated B-cell-like type of diffuse large B-cell lymphoma.
Iqbal J; Neppalli VT; Wright G; Dave BJ; Horsman DE; Rosenwald A; Lynch J; Hans CP; Weisenburger DD; Greiner TC; Gascoyne RD; Campo E; Ott G; Müller-Hermelink HK; Delabie J; Jaffe ES; Grogan TM; Connors JM; Vose JM; Armitage JO; Staudt LM; Chan WC
J Clin Oncol; 2006 Feb; 24(6):961-8. PubMed ID: 16418494
[TBL] [Abstract][Full Text] [Related]
38. Cell-of-Origin in Diffuse Large B-Cell Lymphoma: Are the Assays Ready for the Clinic?
Scott DW
Am Soc Clin Oncol Educ Book; 2015; ():e458-66. PubMed ID: 25993210
[TBL] [Abstract][Full Text] [Related]
39. DNA microarrays in lymphoid malignancies.
Rosenwald A
Oncology (Williston Park); 2003 Dec; 17(12):1743-8; discussion 1750, 1755, 1758-9 passim. PubMed ID: 14723013
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA signature is indicative of long term prognosis in diffuse large B-cell lymphoma.
Shepshelovich D; Ram R; Uziel O; Kushnir M; Lithwick-Yanai G; Hoshen M; Feinmesser M; Bairey O; Lahav M
Leuk Res; 2015 Jun; 39(6):632-7. PubMed ID: 25866097
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]